164 related articles for article (PubMed ID: 38499489)
1. Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization.
Yoshimura T; Yamada R; Kinoshita R; Matsuura T; Kanehira T; Tamura H; Nishioka K; Yasuda K; Taguchi H; Katoh N; Kobashi K; Hashimoto T; Aoyama H
J Radiat Res; 2024 May; 65(3):369-378. PubMed ID: 38499489
[TBL] [Abstract][Full Text] [Related]
2. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
3. NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT).
Yoshimura T; Kinoshita R; Onodera S; Toramatsu C; Suzuki R; Ito YM; Takao S; Matsuura T; Matsuzaki Y; Umegaki K; Shirato H; Shimizu S
Phys Med; 2016 Sep; 32(9):1095-102. PubMed ID: 27567089
[TBL] [Abstract][Full Text] [Related]
4. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement.
Fellin F; Iacco M; D'Avino V; Tommasino F; Farace P; Palma G; Conson M; Giacomelli I; Zucchetti C; Falcinelli L; Amichetti M; Aristei C; Cella L
Acta Oncol; 2019 Jun; 58(6):934-942. PubMed ID: 30938217
[No Abstract] [Full Text] [Related]
5. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
[TBL] [Abstract][Full Text] [Related]
7. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
8. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
[TBL] [Abstract][Full Text] [Related]
9. Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.
de Boer P; van de Schoot AJAJ; Westerveld H; Smit M; Buist MR; Bel A; Rasch CRN; Stalpers LJA
Strahlenther Onkol; 2018 Mar; 194(3):255-263. PubMed ID: 29101415
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer.
Oonsiri S; Kitpanit S; Kannarunimit D; Chakkabat C; Lertbutsayanukul C; Prayongrat A
Phys Imaging Radiat Oncol; 2022 Apr; 22():51-56. PubMed ID: 35514527
[TBL] [Abstract][Full Text] [Related]
11. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies.
Wark A; Gupta A; Meixner E; König L; Hörner-Rieber J; Forster T; Lang K; Ellerbrock M; Herfarth K; Debus J; Arians N
Technol Cancer Res Treat; 2024; 23():15330338241252622. PubMed ID: 38845139
[No Abstract] [Full Text] [Related]
13. An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours.
Lideståhl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
Phys Med; 2019 Apr; 60():120-126. PubMed ID: 31000071
[TBL] [Abstract][Full Text] [Related]
14. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ
Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
17. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
18. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
19. Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
Chuong MD; Hartsell W; Larson G; Tsai H; Laramore GE; Rossi CJ; Wilkinson JB; Kaiser A; Vargas C
Acta Oncol; 2018 Mar; 57(3):368-374. PubMed ID: 29034790
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
